Details
Stereochemistry | ACHIRAL |
Molecular Formula | C32H37NO4 |
Molecular Weight | 499.6405 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C(O)=O)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=XGHOVGYJHWQGCC-UHFFFAOYSA-N
InChI=1S/C32H37NO4/c1-32(2,31(35)36)27-17-15-24(16-18-27)29(34)14-9-21-33-22-19-28(20-23-33)37-30(25-10-5-3-6-11-25)26-12-7-4-8-13-26/h3-8,10-13,15-18,28,30H,9,14,19-23H2,1-2H3,(H,35,36)
CNS Activity
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11249602
Curator's Comment: Carebastine was first mentioned by Vincent, Liminana, Meredith and Reid from Stobhill General Hospital, Glasgow https://www.ncbi.nlm.nih.gov/pubmed/2905150
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P35367 Gene ID: 3269.0 Gene Symbol: HRH1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/22186623 |
9.7 nM [Ki] | ||
Target ID: GO:0001525 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19357149 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice. | 2009 Dec |
|
Inverse agonistic activity of antihistamines and suppression of histamine H1 receptor gene expression. | 2012 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11249602
In Phase III clinical trials patients were treated with a nasal spray containing Carebastine in a concentration of 2.5 mg/mL, and as an eye drop containing Carebastine at a concentration of 25 mg/mL.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22186623
In a dose–response study: CHO-H1R cells were incubated with Carebastine (1 nM – 1 μM) for 1 h. Effectiveness was assessed by measuring the accumulation of inositol phosphates.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL67654
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
C058251
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
90729-42-3
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
C77432
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
75DLN707DO
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
65820
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
DTXSID60238246
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
SUB06623MIG
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
100000084571
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY | |||
|
5634
Created by
admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (METABOLITE)